Podcast Episodes
Back to SearchCLL at ASH 2025: Time Limited Triplet, Timing of Anti-CD20 Therapy, and GAIA/CLL13
Episode 648
Drs. Wierda and O’Brien discuss new combination treatments for CLL that achieve exceptionally high rates of undetectable disease, especially with tri…
2 months, 3 weeks ago
2026 Macula Society Meeting: New Developments for Retinal Diseases
Episode 647
Drs. Yiu and Emami continue their wrap-up of the highlights from the 49th Annual Macula Society Meeting, focusing on new developments in imaging tech…
2 months, 3 weeks ago
HER2+ Genitourinary Cancers: Targeted Therapy Highlights From ESMO 2025
Episode 646
Drs. Mantia and Berg continue their discussion of ESMO 2025 data on HER2‑directed antibody–drug conjugates in urothelial cancer and the importance of…
2 months, 3 weeks ago
Could a new oral pan-RAS inhibitor finally change the outlook for KRAS-mutated pancreatic cancer?
Episode 645
This episode of the PeerDirect Medical News Podcast explores promising new data on the oral pan-RAS inhibitor daraxonrasib in KRAS-mutated pancreatic…
2 months, 4 weeks ago
ATTR-CM in 2026: Stabilizers vs Silencers – How Are You Choosing?
Episode 644
Drs. Sarswat and Dasgupta discuss contemporary decision-making in treating transthyretin amyloidosis, comparing oral stabilizers with subcutaneous si…
2 months, 4 weeks ago
Highlights From ISC 2026: The CREST-2 Cognitive Substudy and Oral Health and Stroke Risk
Episode 641
Drs. Sanossian and Saver highlight emerging evidence that routine dental care and oral hygiene may function as actionable, modifiable contributors to…
3 months, 1 week ago
AI, Machine Learning, and HRCT in ILD: Fibrosis Quantification
Episode 640
Drs. Swigris and Humphries discuss how data-driven texture analysis (DTA) on HRCT enables precise, objective quantification of fibrotic burden in ILD…
3 months, 1 week ago
HER2 in Genitourinary Cancers: Clinical Relevance and Real-World Testing Considerations
Episode 639
Drs. Mantia and Berg discuss HER2 as a biomarker in genitourinary cancers, focusing on testing strategies, prevalence, and the clinical implications …
3 months, 2 weeks ago
Could first-line ablation soon replace antiarrhythmic drugs for persistent atrial fibrillation?
Episode 638
New cardiovascular data suggest pulsed field ablation may challenge antiarrhythmic drugs as first-line therapy for persistent atrial fibrillation, wh…
3 months, 2 weeks ago
CLL and ASH 2025: CAR T-cell Therapy and Data on Vaccination and Cancer Screening
Episode 637
Drs. Wierda and O’Brien discuss how fixed-duration venetoclax-based therapy can match continuous BTK inhibitor treatment in CLL while offering deep r…
3 months, 2 weeks ago